Dr Amy Wilson-O'Brien : Find an Expert : The University of Melbourne

99 Scholarly works

0 Projects

2025
Journal article
555: DEVELOPMENT OF A RATIONALLY DESIGNED BACTERIAL CONSORTIUM THAT CAN RESTORE GUT HOMEOSTASIS AND IMPROVE THERAPEUTIC RESPONSE IN CROHN’S DISEASE
DOI: 10.1016/s0016-5085(25)01265-x
2025
Journal article
Practical Application of Evidence-Based Dietary Therapy in Inflammatory Bowel Disease: The DELECTABLE Program
DOI: 10.3390/nu17091592
2025
Journal article
Su1973: FUNCTIONAL AND TAXONOMIC BIOMARKERS OF CROHN’S DISEASE AND HEALTH FROM THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA. THE ENIGMA STUDY.
DOI: 10.1016/s0016-5085(25)03034-3
2025
Journal article
1330: PROTEUS MIRABILIS PROMOTES POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE THROUGH LYMPHATIC TRANSLOCATION AND ABERRANT IMMUNE ACTIVATION ELICITED BY INTESTINAL RECOLONIZATION
DOI: 10.1016/s0016-5085(25)01708-1
2025
Journal article
Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol
DOI: 10.1136/bmjopen-2024-094714
2024
Journal article
Noninvasive, microbiome-based diagnosis of inflammatory bowel disease
DOI: 10.1038/s41591-024-03280-4
2024
Journal article
Sa1856 CROHN'S DISEASE MUCOSAL MICROBIOTA VIRULENCE FACTOR GENE ANALYSIS IDENTIFIES ANTIBIOTIC RESISTANT ENTEROCOCCUS FAECALIS LINKED TO IMMUNE ACTIVATION. THE ENIGMA STUDY
DOI: 10.1016/s0016-5085(24)01741-4

2024
Journal article
Sa1858 THE ROLE OF PROTEUS MIRABILIS AND ITS DERIVED METABOLITE CADAVERINE IN ALTERING BACTERIAL COMPOSITION AND METABOLITE PROFILE IN CROHN'S DISEASE
DOI: 10.1016/s0016-5085(24)01743-8
2024
Journal article
Sa1857 THE KEY ANTI-INFLAMMATORY BACTERIUM FAECALIBACTERIUM PRAUSNITZII IS MORE COMPLEX AND DIVERSE THAN PREVIOUSLY RECOGNISED: ANATOMIC, GEOGRAPHIC, AND GENOMIC DIFFERENCES IN THE EAST AND WEST AND IN HEALTH AND CROHN'S DISEASE. THE ENIGMA STUDY.
DOI: 10.1016/s0016-5085(24)01742-6
2023
Journal article
Clinical outcomes amongst elderly patients with inflammatory bowel disease
DOI: 10.1111/imj.15928